Community Trust & Investment Co. Boosts Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

Community Trust & Investment Co. boosted its position in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 4.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 77,240 shares of the medical research company's stock after purchasing an additional 3,634 shares during the period. Community Trust & Investment Co.'s holdings in IQVIA were worth $15,178,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Capital Performance Advisors LLP bought a new position in shares of IQVIA in the third quarter worth about $27,000. Park Place Capital Corp bought a new stake in IQVIA during the 3rd quarter valued at approximately $28,000. Itau Unibanco Holding S.A. bought a new stake in IQVIA during the 2nd quarter valued at approximately $29,000. Avior Wealth Management LLC raised its stake in IQVIA by 117.6% during the 3rd quarter. Avior Wealth Management LLC now owns 161 shares of the medical research company's stock valued at $38,000 after purchasing an additional 87 shares during the period. Finally, Assetmark Inc. raised its stake in IQVIA by 612.5% during the 3rd quarter. Assetmark Inc. now owns 228 shares of the medical research company's stock valued at $54,000 after purchasing an additional 196 shares during the period. 89.62% of the stock is owned by hedge funds and other institutional investors.

IQVIA Stock Down 1.0 %

NYSE:IQV traded down $1.95 during mid-day trading on Wednesday, hitting $196.01. 1,711,321 shares of the company's stock traded hands, compared to its average volume of 1,307,612. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The company has a fifty day moving average of $201.43 and a 200 day moving average of $221.61. The company has a market capitalization of $35.58 billion, a P/E ratio of 25.72, a P/E/G ratio of 2.05 and a beta of 1.48. IQVIA Holdings Inc. has a twelve month low of $187.62 and a twelve month high of $261.73.

Analysts Set New Price Targets

Several research firms have weighed in on IQV. Evercore ISI cut their price target on IQVIA from $270.00 to $265.00 and set an "outperform" rating for the company in a report on Tuesday, October 8th. Redburn Atlantic began coverage on IQVIA in a report on Monday, October 14th. They set a "buy" rating and a $276.00 price target for the company. Truist Financial cut their price target on IQVIA from $265.00 to $261.00 and set a "buy" rating for the company in a report on Thursday, December 12th. BTIG Research dropped their target price on IQVIA from $290.00 to $260.00 and set a "buy" rating for the company in a report on Friday, November 1st. Finally, Bank of America dropped their target price on IQVIA from $255.00 to $235.00 and set a "buy" rating for the company in a report on Friday, December 13th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $255.82.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.